An alcohol-free pharmaceutical or cosmetic carrier comprises a foamable composition and a liquified or compressed gas propellant in a container. The foamable composition comprises (wt.%) a liquid, non-volatile hydrophobic solvent (2 - 75), water (80 - 98), a foam adjuvant (0.1 - 5), a surface-active agent (0.1 - 5) and water gelling agent (0.1 - 5). An alcohol-free pharmaceutical or cosmetic carrier (C1) comprises a foamable composition (C2) and a liquified or compressed gas propellant in a container. (C2) comprises (wt.%) a liquid, non-volatile hydrophobic solvent (2 - 75), water (80 - 98), a foam adjuvant (0.1 - 5), a surface-active agent (0.1 - 5) and water gelling agent (0.1 - 5). The foam adjuvant agent is selected from fatty alcohols, fatty acids, hydroxyl substituted fatty alcohols, hydroxyl-substituted fatty acids, and fatty acids and fatty alcohols including at least one double bond in its carbon atom chain. An independent claim is included for a pharmaceutical or cosmetic composition (C3) comprising (C1) and an active agent. ACTIVITY : Dermatological； Antibacterial； Fungicide； Antiparasitic； Virucide； Cytostatic； Antiseborrheic； Vulnerary； Antiinflammatory； Immunosuppressive； Antipsoriatic. Patient with mild or moderate psoriasis was administered with composition containing mineral oil, isopropyl myristate, MCT oil, stearyl alcohol, water, SP70 (RTM； sucrose ester), Tween 80 (RTM), distilled monoglyceride, xanthan gum, ELV 15 (RTM； methocel) betamethasone dipropionate, twice daily. The patient improved significantly by clearing psoriatic plaques flattening of the thickened lesions. MECHANISM OF ACTION : None given.
